Inspire Investing, LLC Clovis Oncology, Inc. Transaction History

Inspire Investing, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$3.77 - $11.0 $60,565 - $176,715	-16,065 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$3.0 - $16.43 $74,919 - $410,306	-24,973 Reduced 60.85%	16,065 $167,000
Q3 2019 Nov 13, 2019	BUY	$3.93 - $15.35 $117,086 - $457,322	29,793 Added 264.94%	41,038 $161,000
Q2 2019 Jul 16, 2019	BUY	$12.81 - $25.67 $144,048 - $288,659	11,245 New	11,245 $167,000
Q1 2018 Apr 13, 2018	SELL	$50.12 - $67.72 $44,456 - $60,067	-887 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$57.69 - $84.58 $51,171 - $75,022	887	887 $60,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.